• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

2.860 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Myriad Genetics, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
News headline image
Myriad Genetics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗
December 09, 2024
 
Via Benzinga
News headline image
This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗
December 09, 2024
 
Via Benzinga
News headline image
NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'Advanced Tool' Recommended for Prognostic Assessment
December 09, 2024
Prolaris Remains a Long-Standing Fixture in the Guidelines for 10th Year Running 
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
November 20, 2024
Agreement will expand worldwide access and better position Myriad’s GIS as a potential companion diagnostic across multiple potential tumor types 
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Where Myriad Genetics Stands With Analysts ↗
November 18, 2024
 
Via Benzinga
News headline image
Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy
November 19, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
November 14, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch
November 13, 2024
SneakPeek®, the first at-home early fetal sex test for use at six weeks, is now available at over 8,800 retail locations nationwide 
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Analyst Expectations For Myriad Genetics's Future ↗
September 19, 2024
 
Via Benzinga
News headline image
Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance
November 07, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
MYGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Myriad Genetics, Inc. and Encourages Investors to Contact the Firm
November 07, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing
November 04, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) ↗
August 13, 2024
 
Via Benzinga
News headline image
Crude Oil Moves Higher; Apple Shares Slide After Q4 Results ↗
November 01, 2024
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
November 01, 2024
 
Via Benzinga
News headline image
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results ↗
November 01, 2024
 
Via Benzinga
News headline image
Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024
October 30, 2024
Management will also participate in two upcoming investor healthcare conferences 
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access
October 16, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration
October 15, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer
October 08, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics
October 03, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
October 01, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference
September 18, 2024
MyRisk®, FirstGene®, Prequel®, and Foresight® studies among 10 datasets to be shared by Myriad 
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday ↗
September 05, 2024
 
Via Benzinga
News headline image
Myriad Genetics to Host Investor Event on October 9, 2024
September 05, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
August 21, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Thermo Fisher Scientific Stock Sees RS Rating Jump To 81 ↗
August 13, 2024
Thermo Fisher Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 77 to 81. 
Via Investor's Business Daily
News headline image
MYGN Stock Earnings: Myriad Genetics Beats EPS, Beats Revenue for Q2 2024 ↗
August 06, 2024
MYGN stock results show that Myriad Genetics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
August 06, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio Scientific
August 01, 2024
From Myriad Genetics, Inc.
Via GlobeNewswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap